1. Home
  2. GAUZ vs MDWD Comparison

GAUZ vs MDWD Comparison

Compare GAUZ & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GAUZ
  • MDWD
  • Stock Information
  • Founded
  • GAUZ 2009
  • MDWD 2000
  • Country
  • GAUZ Israel
  • MDWD Israel
  • Employees
  • GAUZ N/A
  • MDWD N/A
  • Industry
  • GAUZ Industrial Machinery/Components
  • MDWD Medicinal Chemicals and Botanical Products
  • Sector
  • GAUZ Miscellaneous
  • MDWD Health Care
  • Exchange
  • GAUZ Nasdaq
  • MDWD Nasdaq
  • Market Cap
  • GAUZ 193.8M
  • MDWD 184.8M
  • IPO Year
  • GAUZ 2024
  • MDWD 2014
  • Fundamental
  • Price
  • GAUZ $12.74
  • MDWD $18.28
  • Analyst Decision
  • GAUZ Strong Buy
  • MDWD Strong Buy
  • Analyst Count
  • GAUZ 4
  • MDWD 1
  • Target Price
  • GAUZ $16.25
  • MDWD $25.00
  • AVG Volume (30 Days)
  • GAUZ 58.7K
  • MDWD 67.4K
  • Earning Date
  • GAUZ 02-10-2025
  • MDWD 03-20-2025
  • Dividend Yield
  • GAUZ N/A
  • MDWD N/A
  • EPS Growth
  • GAUZ N/A
  • MDWD N/A
  • EPS
  • GAUZ N/A
  • MDWD N/A
  • Revenue
  • GAUZ $94,346,000.00
  • MDWD $19,720,000.00
  • Revenue This Year
  • GAUZ $34.69
  • MDWD $10.15
  • Revenue Next Year
  • GAUZ $35.73
  • MDWD $25.62
  • P/E Ratio
  • GAUZ N/A
  • MDWD N/A
  • Revenue Growth
  • GAUZ 29.76
  • MDWD N/A
  • 52 Week Low
  • GAUZ $6.78
  • MDWD $11.04
  • 52 Week High
  • GAUZ $17.10
  • MDWD $24.00
  • Technical
  • Relative Strength Index (RSI)
  • GAUZ N/A
  • MDWD 53.80
  • Support Level
  • GAUZ N/A
  • MDWD $17.47
  • Resistance Level
  • GAUZ N/A
  • MDWD $18.79
  • Average True Range (ATR)
  • GAUZ 0.00
  • MDWD 0.97
  • MACD
  • GAUZ 0.00
  • MDWD 0.05
  • Stochastic Oscillator
  • GAUZ 0.00
  • MDWD 65.26

About GAUZ Gauzy Ltd. Ordinary Shares

Gauzy Ltd is a integrated light and vision control company, Its products include suspended particle device, or SPD, and liquid crystal, or LC, films for smart glass applications, as well as camera monitoring systems, or CMS, and other advanced driver assistance systems, or ADAS, solutions. It has three operating segments. Architecture and automotive segment focuses on sales that enable OEMs to incorporate the Company's technology in glass rooftops, side windows and windshields. Safety tech segment focuses on sales of advanced driver assistance systems for buses, coaches, recreational vehicles and specific vehicles. Aeronautics segment focuses on the sale of shading and cabin management systems in private and commercial aircraft and helicopters. Key revenue is generated from Aeronauctis.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: